Biopharmaceutical Chief Executive Officers (CEO) Roundtable
The Biopharmaceutical Chief Executive Officers (CEO) Roundtable is a global policy forum organized by IFPMA.
Overview
The Biopharmaceutical CEOs Roundtable (BCR) is a global policy platform that brings together the CEOs of IFPMA member companies, to discuss pressing global health challenges and how the industry can contribute to shaping public health policy.
Medicines and vaccines create a healthier future for us all. Through engagement with governments and multilateral organizations, BCR aims to champion pharmaceutical innovation as a driver of societal and economic progress, and to ensure that scientific and medical innovation translates into better health outcomes, stronger health systems, and enhanced global health security.
BCR supported Initiatives
AMR Action Fund
The AMR Action Fund, the largest private/public initiative in this field, launched in 2019 with USD 1 billion funding principally raised by innovative pharmaceutical companies that aims to bring 2-4 new antibiotics to patients by 2030.
Pandemic Preparedness – Berlin Declaration
Drawing from lessons learned from the global response to COVID-19, IFPMA launched the Berlin Declaration. This sets out an approach to more equitable pandemic preparedness and response based on collaboration, commitments, and contributions across the global health community.
Past meetings
See allBiopharmaceutical CEOs Roundtable met in Berlin
12 NOVEMBER 2025, Berlin – The Biopharmaceutical CEOs Roundtable (BCR), a global policy platform representing the world’s leading biopharmaceutical companies, convened last week in Berlin to discuss how pharmaceutical innovation can drive better health outcomes, strengthen economies, and enhance global health security. The BCR delegation also met with Federal Chancellor Merz, along with key members...
Read moreBiopharmaceutical CEO Roundtable gathers in London, focusing on global health challenges and role of pharmaceutical innovation
The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met in London. 04 APRIL 2025, London – This week, the Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met with the UK Prime Minister, senior UK Cabinet Ministers and key officials to discuss strengthening global health policies and sustaining...
Read more
Biopharmaceutical CEO Roundtable meets in New York, focusing on challenges and opportunities, role of pharmaceutical innovation
The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met in New York City, on 21 November, to discuss global health challenges and public health policies impacting medical innovation. 22 November 2024, New York City – The CEOs of leading biopharmaceutical companies met in New York City to discuss collaborative solutions that...
Read moreRelated intiatives
See all
AMR Action Fund
The industry-led AMR Action Fund organized by IFPMA is a groundbreaking USD 1 billion initiative that aims to bring 2-4 new antibiotics to patients by 2030.
Chief Ethics and Compliance Officers (CECO) Roundtable
The Chief Ethics and Compliance Officers (CECO) Roundtable is a biannual forum bringing together the most senior executive Ethics & Compliance officers of IFPMA member companies.